Skip to main content
. 2020 May 13;20:102. doi: 10.1186/s12893-020-00745-4

Table 1.

Clinical characteristics of patients

IGFI group (n = 84) Control group (n = 105) P value
Gender, n (%) 0.514
 Male 48 (57.1) 55 (52.4)
 Female 36 (42.9) 50 (47.6)
Age, yr, mean ± SD 59.1 ± 11.1 60.2 ± 9.8 0.478
BMI, kg/m2, mean ± SD 24.6 ± 3.4 23.8 ± 2.7 0.066
ASA score, n (%) 0.279
 1 28 (33.3) 45 (42.9)
 2 50 (59.5) 50 (47.6)
 3 6 (7.1) 10 (9.5)
 4 0 0
Previous abdominal operation, n (%) 0.083
 Yes 17 (20.0) 33 (31.4)
 No 67 (80.0) 72 (68.6)
Preoperative neoadjuvant therapy, n (%)
 NACT 14 (16.7) 30 (28.6) 0.054
 No 70 (83.3) 75 (71.4)
Tumor location, n (%) 0.761
 Ileocecal junction 20 (23.8) 25 (23.8)
 Ascending colon 25 (29.8) 28 (26.7)
 Hepatic flexure 9 (10.7) 18 (17.1)
 Transverse colon 12 (14.3) 10 (9.5)
 Splenic flexure 5 (5.9) 6 (5.7)
 Descending colon 8 (9.5) 8 (7.6)
 High sigmoid colon 5 (5.9) 10 (9.5)